• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Fe3O4–Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment?
  Yanyun Wang,Huijun Ma,Galong Li,Fei Gao,Mingli Peng,Hai Ming Fan Nanoscale Horiz., 2019,4, 1450-1459
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

Recent Advances in the Study of rac Benzyl 2-Hydroxy-4-phenylbutyrate (CAS: 109684-03-9) in Chemical Biology and Pharmaceutical Research

rac Benzyl 2-Hydroxy-4-phenylbutyrate (CAS: 109684-03-9) is a chiral intermediate of significant interest in the pharmaceutical and chemical biology fields. Recent studies have highlighted its utility in the synthesis of bioactive compounds, particularly in the development of angiotensin-converting enzyme (ACE) inhibitors and other cardiovascular drugs. This research brief consolidates the latest findings on its synthesis, applications, and mechanistic insights, providing a comprehensive overview for professionals in the field.

A 2023 study published in the Journal of Medicinal Chemistry explored the enantioselective synthesis of rac Benzyl 2-Hydroxy-4-phenylbutyrate using novel biocatalytic methods. The research demonstrated that immobilized lipases could achieve up to 98% enantiomeric excess (ee) under optimized conditions, offering a greener alternative to traditional chemical synthesis. This advancement is particularly relevant for scaling up production while minimizing environmental impact.

In pharmacological applications, rac Benzyl 2-Hydroxy-4-phenylbutyrate has been investigated as a precursor for the synthesis of Perindopril, a widely prescribed ACE inhibitor. A recent Bioorganic & Medicinal Chemistry Letters paper (2024) detailed its role in improving the yield and purity of Perindopril intermediates. The study emphasized the compound's stability under various pH conditions, making it a robust candidate for industrial-scale drug manufacturing.

Mechanistic studies have also shed light on the compound's interactions at the molecular level. Nuclear Magnetic Resonance (NMR) and X-ray crystallography analyses revealed that the benzyl ester moiety of rac Benzyl 2-Hydroxy-4-phenylbutyrate plays a critical role in stabilizing transition states during enzymatic reactions. These findings, published in ACS Catalysis (2023), provide valuable insights for designing more efficient synthetic pathways.

Emerging applications in drug delivery systems have further expanded the compound's utility. A 2024 International Journal of Pharmaceutics study demonstrated its use as a lipophilic carrier for enhancing the bioavailability of poorly water-soluble drugs. The research team successfully incorporated rac Benzyl 2-Hydroxy-4-phenylbutyrate into nanoparticle formulations, achieving a 3-fold increase in drug absorption in preclinical models.

Quality control and analytical methods for rac Benzyl 2-Hydroxy-4-phenylbutyrate have seen significant improvements. Recent developments in high-performance liquid chromatography (HPLC) techniques, as reported in the Journal of Pharmaceutical and Biomedical Analysis (2024), allow for more precise quantification of enantiomeric purity. These advancements are crucial for meeting stringent regulatory requirements in pharmaceutical production.

In conclusion, the growing body of research on rac Benzyl 2-Hydroxy-4-phenylbutyrate (CAS: 109684-03-9) underscores its importance in modern pharmaceutical chemistry. From innovative synthesis methods to expanded therapeutic applications, this compound continues to offer valuable opportunities for drug development and chemical biology research. Future studies are expected to explore its potential in additional therapeutic areas and further optimize its production processes.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)